The US Department of Justice said yesterday it had dropped legal action against Ranbaxy, the Indian generic drugs maker, after the group stepped up co-operation over regulators' concerns over its manufacturing.

Ranbaxy's shares jumped almost 10 per cent, having long been depressed by escalating investigations from the US Food and Drug Administration, triggering a ban which is still in place that stops the US importing or purchasing the company's drugs.